← Pieter Slegers hub  ·  Research hub  ·  Research library

Brookfield Deep Dive — Part 2: moat, industry, risks & balance sheet

"An invisible wall around the company. A wall built from discipline, reputation, and time." Part two scores the competitive advantage, the three end markets, the risk register and the debt structure — the buy decision still deferred.
2025-DEC-14 · Compounding Quality (Substack) · guest analyst Jochen Vandenbergh, published by Pieter Slegers · written post (part 2 of 5) · read ↗ · transcript · actionable insights
One-line take: the moat is argued from structure and evidence rather than from margins, because "gross margin" and "ROIC" don't apply to a company that sells no product and has no measurable invested capital. Three sources of advantage: size ($1trn+ AUM buys deal access and cheaper debt), permanent capital (unlike closed-end funds forced to sell after 7–10 years, Brookfield can hold and improve assets for decades — a snowball), and trust (100+ years of keeping promises opens doors to projects, partners and capital). The proof is in the record: 19%/yr for 30+ years, AUM compounding 15.7% since 2012, Fee-Related Earnings compounding 24.2% over ten years at a 57% FRE margin. Industry: three good markets at once — essential real assets (with an explicit AI/data-centre/power angle), alternative asset management, and retirement/insurance riding ageing plus the defined-benefit → defined-contribution shift. Risks are itemised per division (complexity/transparency, leverage and refinancing, dependence on selling assets, fundraising cycles, reputation, regulation, float mismatch, climate, cyber) and then netted off: "a three-legged stool that can still stand even if one leg wobbles." Balance sheet: 47% debt-to-capitalization group-wide but only 21% at the parent, with 94% of debt non-recourse and $159bn of deployable capital. Scores: moat 8.5, industry 9, risks 8, balance sheet 8, capital intensity 8.

1. Stocks & names mentioned

Stance reflects how the name is framed in this post. Only BN gets a row; Blackstone, KKR, Berkshire Hathaway and Fairfax appear once each in a competitor list the post declines to analyse ("a full operational comparison would be too complicated and not very useful") and are left to the talking points. Research legend: QT Qualtrim · SA Seeking Alpha · STK Stock Analysis. Written post with no timestamps — the At link opens the article.

TickerNameResearchViewWhat he saidAt
BNBrookfield CorporationQT · SA · STK · FANeutralDeep-dive still in progress; the buy decision remains deferred to the final part. "One of the strongest compounders in the world" — a moat of size, permanent capital and 100+ years of trust, evidenced by 19%/yr for 30 years, AUM +15.7% CAGR since 2012 and FRE +24.2% CAGR at a 57% margin; three attractive end markets; risks real but diversified ("a three-legged stool"); 94% of debt non-recourse with $159bn deployable. Part-2 scores: moat 8.5/10 · industry 9/10 · risks 8/10 · balance sheet 8/10 · capital intensity 8/10.read ↗

Stance = how the name is framed in this instalment, not a price rating. Parts 3–5 (capital allocation and profitability, growth/outlook/valuation, and the buy decision) were not part of this archive capture. The transferable method is on the actionable insights page.

2. Talking points

Three sources of the moat: size, permanent money, trust

Why the usual moat numbers don't apply — and what replaces them

The competitor set it refuses to model

Industry 1 — essential real assets, plus the AI power angle

Industry 2 — alternative asset management

Industry 3 — Wealth Solutions and the pension shift

The risk register, division by division

Why the risks net out — the three-legged stool

The balance sheet — where the debt actually sits

Capital intensity, division by division

Part-2 scorecard

3. In plain English

A jargon-free summary of the thesis. (Renders on the name's consolidated page.)

BN — Brookfield Corporation Neutral

Part two asks the obvious question about a company like this: what actually stops a rival from copying it? The answer given is three things that only accumulate with time. Sheer size — over a trillion dollars — means Brookfield can bid for deals nobody else can finance and can borrow more cheaply than smaller buyers. Permanence — most investment funds are obliged to sell everything within seven to ten years because the money is borrowed from clients who want it back, whereas Brookfield owns the funds and invests its own capital too, so it can hold a hydro dam for thirty years and keep improving it. And trust — a hundred years of paying what it promised is why governments and pension funds return its calls.

You cannot check that with the usual ratios: a company that sells no product has no gross margin, and one spread across hundreds of funds has no measurable "invested capital" to divide profits by. So the evidence offered is the record instead — 19% a year for three decades, client money growing about 16% a year since 2012, and the fees earned on that money growing 24% a year with 57 cents of every fee dollar dropping through as profit.

On risk, the post is unusually blunt: the structure is complex and hard to see through, much of it is financed with borrowed money, and the model depends on being able to sell mature assets when it wants to. The mitigation is structural rather than reassuring words — 94% of the debt is "non-recourse", meaning it is attached to one specific building or power plant, so if that project fails the lender can take the project and nothing else. At the parent company itself, debt is only 21% of capital, and there is $159bn of cash and credit ready to deploy. The stance stays Neutral because this is instalment two of five: the scores are 8 to 9 out of 10 throughout, but the decision to buy is explicitly held back until the valuation work is done.


Summary derived from the archived Compounding Quality post (text in transcript.txt) for personal study. Not investment advice. © Compounding Quality — guest analyst Jochen Vandenbergh / Pieter Slegers for source material.